Skip to main content Accessibility help
×
Home

The Diagnosis and Assessment of Individuals Prodromal for Schizophrenic Psychosis

  • Jean Addington

Abstract

Accurate identification of individuals in the earliest symptomatic stages of psychosis offers new hope for developing more effective treatment strategies. Recently, research clinics have been set up to identify and possibly treat individuals who are seen as being at ultra-high risk of developing a psychotic disorder. This article reviews and describes measures that are currently being used and further developed in order to determine both the diagnostic criteria for the prodromal state and the severity of these putatively prodromal symptoms.

Copyright

Corresponding author

Please direct all correspondence to: Jean Addington, PhD, Centre for Addiction and Mental Health, 250College St., Toronto, Ontario, M5S 2S1, Canada; Tel: 416-535-8501 ext. 4360, Fax: 416-979-8501; E-mail: jean_addington@camh.net.

References

Hide All
1. McGorry, PD, Jackson, HJ, eds. The Recognition and Management of Early Psychosis. Cambridge, England: Cambridge University Press; 1999.
2. McGlashan, TH, Zipursky, R, Perkins, DO et al. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res. 2003;61:718.
3. Cornblatt, B, Obuchowski, M. Update of high-risk research: 1987-1997. International Review of Psychiatry. 1997;9:437447.
4. Yung, AR, McGorry, PD, McFarlane, CA, Patton, GC, Rakkar, A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22:283303.
5. Yung, AR, McGorry, PD. The initial prodrome in psychosis: descriptive and qualitative aspects. Aust N Z J Psychiatry. 1996;30:587599.
6. Yung, AR, McGorry, PD. The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull. 1996;22:353370.
7. McGorry, PD, Yung, A, Phillips, LEthics and early intervention in psychosis: keeping up the pace and staying in step. Schizophr Res. 2001;51:1729.
8. Yung, AR, Phillips, L, McGorry, PD et al. Prediction of psychosis. Br J Psychiatry. 1998;172(suppl 33):1420.
9. Miller, TJ, McGlashan, TH, Rosen, JL et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159:863865.
10. Yung, AR, Phillips, LJ, Yuen, H et al. Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr Res. 2003;60:2132.
11. Schaffner, KF, McGorry, PD. Preventing severe mental illnesses--new prospects and ethical challenges. Schizophr Res. 2001;51:315.
12. Chapman, LJ, Chapman, JP. The search for symptoms predictive of schizophrenia. Schizophr Bull. 1987;13:497503.
13. Chapman, LJ, Chapman, JP, Kwapil, TR, Eckblad, M, Zinser, MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 1994;103:171183.
14. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed-rev. Washington, DC: American Psychiatric Association; 1987.
15. Jackson, HJ, McGorry, PD, Dudgeon, P. Prodromal symptoms of schizophrenia in first-episode psychosis: prevalence and specificity. Compr Psychiatry. 1995;36:241250.
16. Yung, AR, Phillips, LJ, McGorry, PD, Ward, JL, Thompson, K. The Comprehensive Assessment of At-Risk Mental States (CAARMS). Melbourne, Australia: University of Melbourne; 2000.
17. Diagnostic and Statistical Manual of Mentd Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
18. Miller, TJ, McGlashan, TH, Woods, SW et al. Symptom assessment in schizophrenic prodromal states. Psychiatr Q. 1999;70:273287.
19. McGlashan, TH. Psychosis treatment prior to psychosis onset: ethical issues. Schizophr Res. 2001;51:4754.
20. Hawkins, KA, McGlashan, TH, Quinlan, D et al. Factorial structure of the Scale of Prodromal Symptoms. Schizophr Res. 2004;61:339347.
21. Gross, G. The ‘basic’ symptoms of schizophrenia. Br J Psychiatry. 1989;155(suppl):2125.
22. Klosterkötter, J. The meaning of basic symptoms for the development of schizophrenic psychosis. Neur Psychiatr Brain Res. 1992;1:3041.
23. Klosterkötter, J, Gross, G, Huber, G, Wieneke, A, Steinmeyer, EM, Schultze-Lutter, F. Evaluation of the ‘Bonn Scale for the Assessment of Basic Symptoms– BSABS’ as an instrument for the assessment of schizophrenia proneness: a review of recent findings. Neur Psychiatr Brain Res. 1997;5:137150.
24. Klosterkötter, J, Hellmich, M, Steinmeyer, EM, Schultze-Lutter, F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158164.
25. Wieneke, A, Schultz-Lutter, F, Picker, H, Steinmeyer, EM, Klosterkötter, J. The Schizophrenia Prediction Instrument (SPI-A): first preliminary results of the evaluation study. Schizophr Res. 2002;53:37.
24. Addington, J. The prodromal stage of psychotic illness: observation, detection, or intervention? J Psychiatry Neurosci. 2003;28:9397.
25. McGorry, PD, Yung, A, Phillips, L et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59:921928.
26. Woods, SW, Breier, A, Zipursky, RB et al. Randomized trial of olanzapine vs placebo in the symptomatic treatment of patients meeting criteria for the schizophrenic prodrome. Biol Psychiatry. 2003;54:453464.

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed